Genom&Company corrects stock option grant: lower exercise price and increased shares

Correction filing: On May 14, 2026, amendment to the initial stock option grant disclosure of March 28, 2024.
Grantees: 34 → 17 persons; shares granted: 714,000 → 1,318,000 shares; exercise price: 9,940 won → 3,040 won.
Key change: Hong Yoosuk (registered executive) granted 1,200,000 shares (previously 600,000), and 15 others granted 118,000 shares.
Fair value calculation: Black-Scholes model; exercise price 3,040 won; stock price 9,130 won; volatility 56.84%; risk-free rate 3.15~3.67%.
Exercise period: March 29, 2026 ~ March 28, 2033.
Total outstanding after grant: 4,092,568 shares.